Form 4: Vericel Corp Director Paul Wotton Reports Stock Transactions

Director Paul Wotton reports acquisition and disposal of Vericel Corp common stock and derivative securities due to vesting of restricted stock units and stock option grants.

Summary

• On April 30, 2025, Paul Wotton, a director of Vericel Corp, reported transactions involving the company's stock.
• Wotton acquired 3,200 shares of common stock through the vesting of Restricted Stock Units (RSUs) granted on May 1, 2024.
• Following the transaction, Wotton directly owns 30,602 shares of Vericel Corp common stock.
• Wotton also acquired 8,000 stock options with an exercise price of $38.02, vesting over a 1-year period and expiring on April 30, 2035.
• Additionally, Wotton acquired 3,200 RSUs that vest on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The vesting of RSUs and granting of stock options to a director could be seen as an incentive to align the director's interests with those of the shareholders.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors and officers.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's view of the company's prospects.

Key Dates

Keywords

Vericel Corp, Paul Wotton, Director, Stock Options, Restricted Stock Units, VCEL, Beneficial Ownership, Form 4